Ekso Bionics Holdings Inc
NASDAQ:EKSO
Balance Sheet
Balance Sheet Decomposition
Ekso Bionics Holdings Inc
Current Assets | 20.5m |
Cash & Short-Term Investments | 8.8m |
Receivables | 5.8m |
Other Current Assets | 5.9m |
Non-Current Assets | 8.4m |
PP&E | 2.8m |
Intangibles | 5.2m |
Other Non-Current Assets | 440k |
Current Liabilities | 7.3m |
Accounts Payable | 1.9m |
Accrued Liabilities | 2.2m |
Other Current Liabilities | 3.3m |
Non-Current Liabilities | 7.6m |
Long-Term Debt | 4.6m |
Other Non-Current Liabilities | 3m |
Balance Sheet
Ekso Bionics Holdings Inc
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
25
|
20
|
17
|
28
|
8
|
11
|
13
|
40
|
21
|
9
|
|
Cash |
25
|
20
|
17
|
28
|
8
|
11
|
13
|
40
|
21
|
9
|
|
Total Receivables |
2
|
2
|
2
|
3
|
4
|
5
|
3
|
5
|
5
|
6
|
|
Accounts Receivables |
2
|
2
|
2
|
3
|
4
|
5
|
3
|
5
|
5
|
6
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
1
|
1
|
2
|
3
|
3
|
2
|
2
|
2
|
5
|
5
|
|
Other Current Assets |
2
|
3
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
|
Total Current Assets |
29
|
25
|
21
|
35
|
15
|
19
|
18
|
48
|
31
|
20
|
|
PP&E Net |
2
|
3
|
2
|
2
|
2
|
3
|
2
|
1
|
4
|
3
|
|
PP&E Gross |
2
|
3
|
2
|
0
|
2
|
3
|
2
|
1
|
4
|
3
|
|
Accumulated Depreciation |
2
|
2
|
3
|
0
|
4
|
4
|
5
|
5
|
3
|
3
|
|
Intangible Assets |
0
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
5
|
5
|
|
Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Long-Term Assets |
2
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Assets |
33
N/A
|
32
-4%
|
24
-24%
|
38
+56%
|
18
-54%
|
22
+24%
|
21
-6%
|
49
+139%
|
41
-17%
|
29
-29%
|
|
Liabilities | |||||||||||
Accounts Payable |
1
|
3
|
2
|
2
|
3
|
2
|
2
|
3
|
3
|
2
|
|
Accrued Liabilities |
0
|
2
|
3
|
4
|
3
|
2
|
2
|
3
|
3
|
3
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
2
|
2
|
2
|
0
|
0
|
2
|
1
|
|
Other Current Liabilities |
6
|
4
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
2
|
|
Total Current Liabilities |
7
|
9
|
6
|
9
|
10
|
8
|
5
|
7
|
9
|
8
|
|
Long-Term Debt |
0
|
0
|
7
|
5
|
3
|
0
|
3
|
2
|
4
|
5
|
|
Other Liabilities |
4
|
15
|
5
|
3
|
2
|
7
|
8
|
3
|
2
|
3
|
|
Total Liabilities |
11
N/A
|
23
+119%
|
18
-24%
|
17
-7%
|
15
-10%
|
15
+1%
|
16
+7%
|
12
-26%
|
15
+29%
|
16
+6%
|
|
Equity | |||||||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
72
|
91
|
115
|
144
|
171
|
183
|
199
|
209
|
224
|
239
|
|
Additional Paid In Capital |
95
|
100
|
121
|
166
|
174
|
190
|
204
|
246
|
249
|
252
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
|
Total Equity |
23
N/A
|
9
-61%
|
7
-26%
|
21
+228%
|
3
-87%
|
7
+149%
|
4
-35%
|
37
+740%
|
25
-32%
|
13
-50%
|
|
Total Liabilities & Equity |
33
N/A
|
32
-4%
|
24
-24%
|
38
+56%
|
18
-54%
|
22
+24%
|
21
-6%
|
49
+139%
|
41
-17%
|
29
-29%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
1
|
1
|
1
|
4
|
4
|
6
|
8
|
13
|
13
|
15
|
|
Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|